ACKNOWLEDGEMENTS
We thank Professor M. Hickey, Australia for her assistance with the sections on Non-pharmacological and lifestyle interventions, Complementary therapies for vasomotor symptoms, and Pharmacological agents for vasomotor symptoms.
The following attended the Workshop in 2007 and contributed to the previous Recommendations: P. Albertazzi, UK; D. Barlow, UK; E. Berry, Israel; M. H. Birkhäuser, Switzerland; W. Böcker, Germany; M. Brincat, Malta; H. Burger, Australia; C. Christiansen, Denmark; T. J. de Villiers, South Africa; J-M. Foidart, Belgium; M. Gambacciani, Italy; A. R. Genazzani, Italy; V. W. Henderson, USA; K-E. Huang, Taiwan; J. Huber, Austria; C. Kluft, Netherlands; K. Limpaphayom, Thailand; R. A. Lobo, USA; M. A. Lumsden, UK; A. H. MacLennan, Australia; A. MacLennan, Australia; D. Murphy, UK; F. Naftolin, USA; R. E. Nappi, Italy; S. Palacios, Spain; N. Panay, UK; J. H. Pickar, USA; A. Pines, Israel; R. Rizzoli, Switzerland; G. Rosano, Italy; J. Russo, USA; G. Samsioe, Sweden; H. P. G. Schneider, Germany; S. Shapiro, South Africa; R. Sitruk-Ware, USA; S. Skouby, Denmark; J. C. Stevenson, UK; D. W. Sturdee, UK.
Delegates of menopause societies from the following countries participated in the discussions on the Recommendations: Argentina, Australia, Austria, Belgium, Bolivia, Brazil, Bulgaria, Chile, Costa Rica, Croatia, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Finland, France, Germany, Greece, Guatemala, Hungary, Hong Kong, India, Indonesia, Israel, Italy, Japan, Lithuania, Malaysia, Mexico, Netherlands, Nicaragua, Norway, Panama, Peru, Philippines, Romania, Russia, Serbia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States of America, Uruguay.
Conflict of interest The members of the Writing Group report no associations or financial relationships with any pharmaceutical company, other than consultative agreements, honoraria for lecturing at scientific meetings, and research support. Details of all disclosures have been updated and are on file in the IMS Secretariat.
Source of funding The costs of updating the Recommendations have been supported entirely from the funds of the International Menopause Society.